Company Reports (Pharmaceutical) Market Research

Discover indepth market information on companies in Pharma & Healthcare. Our catalogue of reports provide detailed data on companies such as Wyeth, AstraZeneca Plc, Illumina Inc, and Johnson & Johnson.

Stay up-to-date with new products added to this category

Results 1001 - 1100 of 5395 go to 1st page

first

previous 6 7 8 9 10 11 12 13 14 15 16 next

last

Title	Date	Price
Xenoport Inc-Therapeutic Competitors	Sep 2009	£215
Wyeth-Therapeutic Competitors	Sep 2009	£215
XOMA Ltd-Therapeutic Competitors	Sep 2009	£215
XTL Biopharmaceuticals Ltd-Therapeutic Competitors	Sep 2009	£215
ZymoGenetics, Inc.-Therapeutic Competitors	Sep 2009	£215
Watson Pharmaceuticals Inc-Therapeutic Competitors	Sep 2009	£215
Winston Pharmaceuticals, Inc.-Therapeutic Competitors	Sep 2009	£215
Abbott Laboratories-Therapeutic Competitors	Sep 2009	£220
Accentia Biopharmaceuticals Inc-Therapeutic Competitors	Sep 2009	£220
Abraxis BioScience, Inc.-Therapeutic Competitors	Sep 2009	£220
Warner Chilcott Limited-Therapeutic Competitors	Sep 2009	£215
ZIOPHARM Oncology Inc-Therapeutic Competitors	Sep 2009	£215
Accentia Biopharmaceuticals Inc-Detailed Product Pipeline	Sep 2009	£475
Alcon Inc-Detailed Product Pipeline	Sep 2009	£475
Acorda Therapeutics Inc-Detailed Product Pipeline	Sep 2009	£475
Advanced Cell Technology Inc-Detailed Product Pipeline	Sep 2009	£475
Acusphere Inc-Detailed Product Pipeline	Sep 2009	£475
Acura Pharmaceuticals Inc-Detailed Product Pipeline	Sep 2009	£475
Achillion Pharmaceuticals Inc-Detailed Product Pipeline	Sep 2009	£475
Access Pharmaceuticals Inc-Detailed Product Pipeline	Sep 2009	£475
Abraxis BioScience, Inc.-Detailed Product Pipeline	Sep 2009	£475
Abbott Laboratories-Detailed Product Pipeline	Sep 2009	£475
ACADIA Pharmaceuticals Inc-Detailed Product Pipeline	Sep 2009	£475
Alfacell Corp-Detailed Product Pipeline	Sep 2009	£475
ACADIA Pharmaceuticals Inc-Therapeutic Competitors	Sep 2009	£220
Access Pharmaceuticals Inc-Therapeutic Competitors	Sep 2009	£220
Affymax Inc-Therapeutic Competitors	Sep 2009	£220
Antigenics Inc-Therapeutic Competitors	Sep 2009	£220
AEterna Zentaris Inc-Therapeutic Competitors	Sep 2009	£220
Adeona Pharmaceuticals, Inc.-Therapeutic Competitors	Sep 2009	£220
Advaxis Inc-Therapeutic Competitors	Sep 2009	£220
Allergan Inc-Therapeutic Competitors	Sep 2009	£220
AutoImmune Inc-Therapeutic Competitors	Sep 2009	£220
Alliance Pharmaceutical Corporation-Therapeutic Competitors	Sep 2009	£220
Alkermes Inc-Therapeutic Competitors	Sep 2009	£220
Akorn Inc-Therapeutic Competitors	Sep 2009	£220
Antares Pharma Inc-Therapeutic Competitors	Sep 2009	£220
Advanced Viral Research Corp-Therapeutic Competitors	Sep 2009	£220
Advanced Life Sciences Holdings Inc-Therapeutic Competitors	Sep 2009	£220
Acorda Therapeutics Inc-Therapeutic Competitors	Sep 2009	£220
Alcon Inc-Therapeutic Competitors	Sep 2009	£220
Achillion Pharmaceuticals Inc-Therapeutic Competitors	Sep 2009	£220
Alfacell Corp-Therapeutic Competitors	Sep 2009	£220
Advanced Cell Technology Inc-Therapeutic Competitors	Sep 2009	£220
Acura Pharmaceuticals Inc-Therapeutic Competitors	Sep 2009	£220
Adolor Corp-Therapeutic Competitors	Sep 2009	£220
Amdl Inc-Therapeutic Competitors	Sep 2009	£220
Adherex Technologies Inc-Therapeutic Competitors	Sep 2009	£220
Acusphere Inc-Therapeutic Competitors	Sep 2009	£220
Adherex Technologies Inc-Detailed Product Pipeline	Sep 2009	£475
Adolor Corp-Detailed Product Pipeline	Sep 2009	£475
AngioDynamics Inc-Therapeutic Competitors	Sep 2009	£220
Anika Therapeutics Inc-Detailed Product Pipeline	Sep 2009	£475
Angiotech Pharmaceuticals Inc-Detailed Product Pipeline	Sep 2009	£475
Adventrx Pharmaceuticals Inc-Therapeutic Competitors	Sep 2009	£220
Antisense Therapeutics Limited-Company Report	Sep 2009	£475
AnaMar Medical AB-Company Report	Sep 2009	£475
Anadys Pharmaceuticals Inc-Detailed Product Pipeline	Sep 2009	£475
Amgen Inc-Detailed Product Pipeline	Sep 2009	£475
Albany Molecular Research Inc-Detailed Product Pipeline	Sep 2009	£475
Amazon Biotech Inc.-Detailed Product Pipeline	Sep 2009	£475
Amarin Corporation plc-Detailed Product Pipeline	Sep 2009	£475
Apogenix GmbH-Company Report	Sep 2009	£475
Aquapharm Bio-Discovery Ltd-Company Report	Sep 2009	£475
ArQule Inc.-Deals & Alliances Report	Sep 2009	£380
Arteriocyte Medical Systems, Inc.-Company Report	Sep 2009	£475
Aastrom Biosciences Inc-Therapeutic Competitors	Sep 2009	£220
Asterion Ltd-Company Report	Sep 2009	£475
Arno Therapeutics, Inc.-Detailed Product Pipeline	Sep 2009	£475
Arisyn Therapeutics, Inc.-Company Report	Sep 2009	£475
Aradigm Corp-Detailed Product Pipeline	Sep 2009	£475
Archemix Corp.-Company Report	Sep 2009	£475
Auriga Laboratories Inc.-Deals & Alliances Report	Sep 2009	£380
Arena Pharmaceuticals Inc-Detailed Product Pipeline	Sep 2009	£475
Amylin Pharmaceuticals Inc-Detailed Product Pipeline	Sep 2009	£475
Amarillo Biosciences Inc-Detailed Product Pipeline	Sep 2009	£475
Antigenics Inc-Detailed Product Pipeline	Sep 2009	£475
Affymax Inc-Detailed Product Pipeline	Sep 2009	£475
Allergan Inc-Detailed Product Pipeline	Sep 2009	£475
AutoImmune Inc-Detailed Product Pipeline	Sep 2009	£475
Antares Pharma Inc-Detailed Product Pipeline	Sep 2009	£475
Adeona Pharmaceuticals, Inc.-Detailed Product Pipeline	Sep 2009	£475
AEterna Zentaris Inc-Detailed Product Pipeline	Sep 2009	£475
Addrenex Pharmaceuticals, Inc.-Company Report	Sep 2009	£475
Advanced Life Sciences Holdings Inc-Detailed Product Pipeline	Sep 2009	£475
Advaxis Inc-Detailed Product Pipeline	Sep 2009	£475
Advanced Viral Research Corp-Detailed Product Pipeline	Sep 2009	£475
Akorn Inc-Detailed Product Pipeline	Sep 2009	£475
Alkermes Inc-Detailed Product Pipeline	Sep 2009	£475
Allos Therapeutics Inc-Detailed Product Pipeline	Sep 2009	£475
Alexion Pharmaceuticals Inc-Detailed Product Pipeline	Sep 2009	£475
Alexza Pharmaceuticals Inc-Detailed Product Pipeline	Sep 2009	£475
AMAG Pharmaceuticals, Inc.-Detailed Product Pipeline	Sep 2009	£475
Altus Pharmaceuticals Inc-Detailed Product Pipeline	Sep 2009	£475
Altacor-Company Report	Sep 2009	£475
Alliance Pharmaceutical Corporation-Detailed Product Pipeline	Sep 2009	£475
Alnylam Pharmaceuticals Inc-Detailed Product Pipeline	Sep 2009	£475
AlphaRx Inc.-Detailed Product Pipeline	Sep 2009	£475
Alseres Pharmaceuticals, Inc.-Detailed Product Pipeline	Sep 2009	£475
Auxilium Pharmaceuticals Inc-Therapeutic Competitors	Sep 2009	£220